Vinfosiltine
Alternative Names: S 12363Latest Information Update: 26 Jul 1994
At a glance
- Originator Servier
- Class Antineoplastics; Vinca alkaloids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer